Provider review
TeleClinic review
Quotes its three-month option as a total, not as a monthly division.
And publishes no ongoing rate at all for either molecule.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
TeleClinic
$79 first month, or $179 for the first three, ongoing unpublished
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Compounded by 503A referenced
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
The presentation here is better than the disclosure. Quoting a three-month block as a total rather than as a monthly division is the honest way to do it — you see the amount that will actually leave your account instead of an artificially small per-month figure — and attaching no commitment to the introductory rate means the cheap way in is not a lock-in. Both of those are choices most sellers in this category decline to make, and they are worth crediting. What is missing is everything after month three. Neither molecule has an ongoing rate published anywhere on the site, so you can price the beginning of treatment precisely and the continuation not at all. For a medication taken over many months, that is the larger half of the cost, and it is the half a comparison actually turns on. The pharmacy class is referenced; no milligram appears against either figure.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want a three-month price stated as a total rather than divided
- You want an introductory rate with no commitment attached
- You are trying a provider and will ask what month four costs
Look elsewhere if
- You are costing a course. Nothing after the intro period is published
- You want to compare ongoing rates against other providers
- You want a dose behind the number
What it actually costs
Price as published
Two figures per molecule and both are introductory: semaglutide "1st Month Intro $79. No commitment. Or $179 total for first 3 months" and tirzepatide "1st Month Intro $149. No commitment. Or $399 total for first 3 months" · ★ the three-month figure is quoted as a TOTAL rather than divided into a per-month rate, which is the honest way to present a block and rare on this page — a reader sees $179 leaving the account, not $59.67 a month · ★ and "No commitment" is attached to the intro figure, so the cheaper option is not a lock-in · but the ongoing rate after either introductory period is not published anywhere, for either molecule · the 503A class is referenced three times · no milligram is published
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. ★ The three-month option is quoted as a TOTAL rather than as a per-month division, which shows a reader the amount actually leaving their account, and the introductory rate carries no commitment. Both are choices most sellers here decline. But nothing after the introductory period is published for either molecule, so the larger half of a course cannot be costed at all.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- Quotes the three-month option as a total rather than dividing it into a monthly rate.
- Attaches no commitment to the introductory figure, so the cheap entry is not a lock-in.
- Both molecules are priced on the same basis, with the pharmacy class referenced.
Pharmacy, labs and oversight
TeleClinic dispenses through a 503A referenced facility. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
3 of 4 published openly
What TeleClinic publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
The presentation here is better than the disclosure. Quoting a three-month block as a total rather than as a monthly division is the honest way to do it — a reader sees the amount that will actually leave their account instead of an artificially small per-month figure — and attaching no commitment to the introductory rate means the cheap way in is not a trap. Both of those are choices most sellers here decline to make. What is missing is everything after month three. Neither molecule has an ongoing rate published anywhere on the site, so a reader can price the beginning of treatment precisely and the continuation not at all. For a medication taken over many months that is the larger half of the cost. The pharmacy class is referenced; no milligram appears against either figure.
The honest cons
No ongoing rate is published for either molecule after the introductory period.
- Both published figures cover the beginning of treatment only.
- No milligram appears against either figure.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
TeleClinic is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#350 of 373
Ordered with the companies that pay us first, and TeleClinic is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Low dose vs full dose
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.